Type I hyperprolinemia: genotype/phenotype correlations
Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals o...
Saved in:
| Published in | Human mutation Vol. 31; no. 8; pp. 961 - 965 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article Web Resource |
| Language | English |
| Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.08.2010
John Wiley & Sons, Inc Wiley Wiley Liss |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1059-7794 1098-1004 1098-1004 |
| DOI | 10.1002/humu.21296 |
Cover
| Abstract | Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity ≥50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Hum Mutat 31:961-965, 2010. |
|---|---|
| AbstractList | Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity > or = 50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia.Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity > or = 50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity ≥50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Hum Mutat 31:961-965, 2010. Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. 8/14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for 6 novel mutations and 2 haplotypes. The c.1331G>A, p.G444D allele has a drastic effect whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. 8 out of 9 subjects with a predicted residual activity ≥50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity ≥50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Hum Mutat 31:961-965, 2010. © 2010 Wiley-Liss, Inc. Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity > or = 50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. Eight of 14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for six novel mutations and two haplotypes. The c.1331G>A, p.G444D allele has a drastic effect, whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity <50%. Eight out of nine subjects with a predicted residual activity >=50% bore at least one c.824C>A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia. Hum Mutat 31:961-965, 2010. [copy 2010 Wiley-Liss, Inc. |
| Author | Des Portes, Vincent Legallic, Solenn Guilmatre, Audrey Bonafé, Luisa Goldenberg, Alice Le Galloudec, Eric Izzi, Claudia Espil-Taris, Caroline Hoffman, Jodi D Frebourg, Thierry Maurey, Hélène Guet, Agnès Blanchet, Patricia Van Maldergem, Lionel Roubertie, Agathe Mignot, Cyril Afenjar, Alexandra Orcesi, Simona Campion, Dominique Di Rosa, Gabriella Ioos, Christine Echenne, Bernard Valayannopoulos, Vassili Valle, David Steel, Gary Willis, Alecia Drouin-Garraud, Valérie |
| Author_xml | – sequence: 1 fullname: Guilmatre, Audrey – sequence: 2 fullname: Legallic, Solenn – sequence: 3 fullname: Steel, Gary – sequence: 4 fullname: Willis, Alecia – sequence: 5 fullname: Di Rosa, Gabriella – sequence: 6 fullname: Goldenberg, Alice – sequence: 7 fullname: Drouin-Garraud, Valérie – sequence: 8 fullname: Guet, Agnès – sequence: 9 fullname: Mignot, Cyril – sequence: 10 fullname: Des Portes, Vincent – sequence: 11 fullname: Valayannopoulos, Vassili – sequence: 12 fullname: Van Maldergem, Lionel – sequence: 13 fullname: Hoffman, Jodi D – sequence: 14 fullname: Izzi, Claudia – sequence: 15 fullname: Espil-Taris, Caroline – sequence: 16 fullname: Orcesi, Simona – sequence: 17 fullname: Bonafé, Luisa – sequence: 18 fullname: Le Galloudec, Eric – sequence: 19 fullname: Maurey, Hélène – sequence: 20 fullname: Ioos, Christine – sequence: 21 fullname: Afenjar, Alexandra – sequence: 22 fullname: Blanchet, Patricia – sequence: 23 fullname: Echenne, Bernard – sequence: 24 fullname: Roubertie, Agathe – sequence: 25 fullname: Frebourg, Thierry – sequence: 26 fullname: Valle, David – sequence: 27 fullname: Campion, Dominique |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20524212$$D View this record in MEDLINE/PubMed https://hal.science/hal-00599468$$DView record in HAL |
| BookMark | eNqFkU1v1DAQhiNURD_gwg-AlTggkNL6I_4It6pAt9JSDnSB28jx2rsuSbzYSWH_Pc5mt4cKwWlGo-cZ2e8cZwetb02WPcfoFCNEzlZ9058STEr-KDvCqJR5GhcHQ8_KXIiyOMyOY7xFCEnG6JPskCBGimQcZeJmszaTq8kqlbAOvnataZx6N1ma1ndpeLZe7bqJ9iGYWnXOt_Fp9tiqOppnu3qSzT9-uLmY5rPPl1cX57NcM055bqWpGNEVElwgq4uCUqbLhaaaWIslriwWTCgrdaWVWFitLRVmgQyutKjEgp5kZNxbO7M04EPl4I6AV27s-3oJSkNlgBAuQRJBaZLejNJK1bAOrlFhs1Wm5zMYZigFUxZc3uHEvh7Z9PmfvYkdNC5qU9eqNb6PIKVMafKS_5cUtEgJM84S-eoBeev70KacAAvOJZGcDNSLHdVXjVncP3R_nASgEdDBxxiMBe26bfxdUK4GjGC4Pwz3h-39k_L2gbLf-lcYj_AvV5vNP0iYzj_N904-Oi525ve9o8IP4IIKBt-uLwFTJN9fT7_C98S_HHmrPKhlcBHmXwhKBJYC47TxDxhb1zE |
| CitedBy_id | crossref_primary_10_1002_ajmg_b_32416 crossref_primary_10_1055_s_0042_1759534 crossref_primary_10_1016_j_ophtha_2013_06_040 crossref_primary_10_1002_ajmg_b_32869 crossref_primary_10_1016_j_braindev_2017_01_008 crossref_primary_10_1055_s_0042_1759539 crossref_primary_10_1093_hmg_ddy028 crossref_primary_10_1055_s_0042_1759538 crossref_primary_10_1038_s41439_021_00159_5 crossref_primary_10_1007_s11064_011_0555_6 crossref_primary_10_1038_srep31463 crossref_primary_10_1007_s10545_013_9660_9 crossref_primary_10_2174_011573398X283376240222051823 crossref_primary_10_1177_2326409817707772 crossref_primary_10_2174_011573398X289178240528052344 crossref_primary_10_1016_j_schres_2011_05_006 crossref_primary_10_1111_ped_12420 crossref_primary_10_1038_mp_2014_190 crossref_primary_10_1093_gbe_evad045 crossref_primary_10_1007_s11064_016_2015_9 crossref_primary_10_1055_s_0042_1759540 crossref_primary_10_1055_s_0042_1759531 crossref_primary_10_1080_01677063_2021_1892094 |
| Cites_doi | 10.1016/S0920-9964(03)00160-9 10.1073/pnas.232186099 10.1001/archpsyc.56.10.940 10.1001/archgenpsychiatry.2009.80 10.1093/jn/136.1.218S 10.1093/hmg/11.19.2243 10.1002/humu.20796 10.1136/jmg.40.1.e7 10.1086/428142 10.1056/NEJM196506172722401 10.1073/pnas.2235651100 10.1007/s004390050589 10.1038/sj.mp.4001597 10.1093/hmg/ddl443 10.1016/0006-291X(73)91144-3 10.1038/7777 10.1023/A:1026773005303 10.1056/NEJM196207122670201 10.1177/088307380101600820 10.1111/j.1651-2227.1976.tb16538.x 10.1002/humu.20061 |
| ContentType | Journal Article Web Resource |
| Copyright | 2010 Wiley‐Liss, Inc. 2010 Wiley-Liss, Inc. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2010 Wiley‐Liss, Inc. – notice: 2010 Wiley-Liss, Inc. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | FBQ BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK 8FD FR3 K9. P64 RC3 7X8 1XC VOOES Q33 |
| DOI | 10.1002/humu.21296 |
| DatabaseName | AGRIS Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) Université de Liège - Open Repository and Bibliography (ORBI) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Genetics Abstracts MEDLINE Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1098-1004 |
| EndPage | 965 |
| ExternalDocumentID | oai_orbi_ulg_ac_be_2268_82733 oai_HAL_hal_00599468v1 3958183871 20524212 10_1002_humu_21296 HUMU21296 ark_67375_WNG_1308DNHV_X US201301871196 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 169 1L6 1OB 1OC 1ZS 29I 31~ 33P 3SF 3V. 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88A 88E 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 8UM 930 A03 AAESR AAEVG AAHHS AAJEY AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABPVW ABUWG ABWRO ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIMD AENEX AEQDE AEQTP AEUQT AFBPY AFGKR AFKRA AFPWT AFVGU AFZJQ AGJLS AHMBA AIURR AIWBW AJAOE AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BDRZF BENPR BFHJK BHBCM BHPHI BMNLL BMXJE BNHUX BPHCQ BROTX BRXPI BVXVI BY8 C45 CCPQU CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 DVXWH EBD EBS EJD EMOBN F00 F01 F04 F5P FBQ FEDTE FYUFA G-S G.N GNP GODZA H.T H.X HBH HCIFZ HF~ HHY HHZ HMCUK HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LK8 LOXES LP6 LP7 LUTES LW6 LYRES M0L M1P M66 M7P MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2P P2W P2X P4D PALCI PIMPY PQQKQ PROAC PSQYO Q.N Q11 Q2X QB0 QRW R.K RHX RIWAO RJQFR ROL RWI RWV RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 UDS UKHRP V2E W8V W99 WBKPD WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WTM WXSBR WYISQ X7M XG1 XSW XV2 ZZTAW ~IA ~KM ~WT 24P AAMMB AANHP ACCMX ACRPL ACYXJ ADNMO AEFGJ AGQPQ AGXDD AIDQK AIDYY AIQQE ALUQN BSCLL H13 OIG PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO RPM ALIPV AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK 8FD FR3 K9. P64 RC3 7X8 1XC VOOES Q33 |
| ID | FETCH-LOGICAL-c5636-f8eb52cb07670fc44335c9dc3c2ff181bf1757af8cbca7dfccf37ed0e1bc7b7d3 |
| IEDL.DBID | DR2 |
| ISSN | 1059-7794 1098-1004 |
| IngestDate | Fri Jul 25 15:21:32 EDT 2025 Thu Sep 25 06:53:52 EDT 2025 Fri Sep 05 14:47:37 EDT 2025 Fri Sep 05 06:54:54 EDT 2025 Fri Jul 25 10:47:25 EDT 2025 Mon Jul 21 05:40:11 EDT 2025 Tue Jul 01 01:11:56 EDT 2025 Thu Apr 24 23:08:16 EDT 2025 Wed Jan 22 16:53:12 EST 2025 Sun Sep 21 06:19:48 EDT 2025 Wed Dec 27 19:14:51 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Life Sciences |
| Language | English |
| License | http://doi.wiley.com/10.1002/tdm_license_1.1 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5636-f8eb52cb07670fc44335c9dc3c2ff181bf1757af8cbca7dfccf37ed0e1bc7b7d3 |
| Notes | http://dx.doi.org/10.1002/humu.21296 Communicated by Arnold Munnich istex:F4972ED0AD4DE43C619DB147403A5893CD1BDC04 ark:/67375/WNG-1308DNHV-X ArticleID:HUMU21296 A. Guilmatre and S. Legallic contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 scopus-id:2-s2.0-77955085263 |
| ORCID | 0000-0002-8180-4857 0000-0002-5864-9182 0000-0003-0399-4007 |
| OpenAccessLink | https://hal.science/hal-00599468 |
| PMID | 20524212 |
| PQID | 1766828625 |
| PQPubID | 30498 |
| PageCount | 5 |
| ParticipantIDs | liege_orbi_v2_oai_orbi_ulg_ac_be_2268_82733 hal_primary_oai_HAL_hal_00599468v1 proquest_miscellaneous_888100696 proquest_miscellaneous_734000565 proquest_journals_1766828625 pubmed_primary_20524212 crossref_citationtrail_10_1002_humu_21296 crossref_primary_10_1002_humu_21296 wiley_primary_10_1002_humu_21296_HUMU21296 istex_primary_ark_67375_WNG_1308DNHV_X fao_agris_US201301871196 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2010 |
| PublicationDateYYYYMMDD | 2010-08-01 |
| PublicationDate_xml | – month: 08 year: 2010 text: August 2010 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: United States |
| PublicationTitle | Human mutation |
| PublicationTitleAlternate | Hum. Mutat |
| PublicationYear | 2010 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company John Wiley & Sons, Inc Wiley Wiley Liss |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: John Wiley & Sons, Inc – name: Wiley – name: Wiley Liss |
| References | Jacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, Demilly C, Haouzir S, Allio G, Fouldrin G, Drouin V, Bou J, Petit M, Campion D, Frebourg T. 2002. Prodh mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 11:2243-2249. Hawkins RA, O'Kane RL, Simpson IA, Vina JR. 2006. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136:218S-226S. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, Fantini C, Breviere GM, Di Rosa G, Pustorino G, Vogels A, Swillen A, Legallic S, Bou J, Opolczynski G, Drouin-Garraud V, Lemarchand M, Philip N, Gerard-Desplanches A, Carlier M, Philippe A, Nolen MC, Heron D, Sarda P, Lacombe D, Coizet C, Alembik Y, Layet V, Afenjar A, Hannequin D, Demily C, Petit M, Thibaut F, Frebourg T, Campion D. 2007. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 16:83-91. Schafer IA, Scriver CR, Efron ML. 1962. Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness. N Engl J Med 267:51-60. Phang JM, Downing SJ, Valle DL, Kowaloff EM. 1975. A radioisotopic assay for proline oxidase activity. J Lab Clin Med 85:312-317. Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, Lerond J, Allio G, Haouzir S, Tillaux A, Bellegou C, Fouldrin G, Delamillieure P, Menard JF, Dollfus S, D'Amato T, Petit M, Thibaut F, Frebourg T, Campion D. 2005. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 10:479-485. Ohtsuki T, Tanaka S, Ishiguro H, Noguchi E, Arinami T, Tanabe E, Yara K, Okubo T, Takahashi S, Matsuura M, Sakai T, Muto M, Kojima T, Matsushima E, Toru M, Inada T. 2004. Failure to find association between prodh deletion and schizophrenia. Schizophr Res 67:111-113. Humbertclaude V, Rivier F, Roubertie A, Echenne B, Bellet H, Vallat C, Morin D. 2001. Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance. J Child Neurol 16:622-623. Valle D, Downing SJ, Phang JM. 1973. Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochem Biophys Res Commun 54:1418-1424. Efron ML. 1965. Familial hyperprolinemia. report of a second case, associated with congenital renal malformations, hereditary hematuria and mild mental retardation, with demonstration of an enzyme defect. N Engl J Med 272:1243-1254. Maynard TM, Haskell GT, Peters AZ, Sikich L, Lieberman JA, LaMantia A. 2003. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci USA 100:14433-14438. Bender H, Almashanu S, Steel G, Hu C, Lin W, Willis A, Pulver A, Valle D. 2005. Functional consequences of prodh missense mutations. Am J Hum Genet 76:409-420. Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC, Buckland PR. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Hum Mutat 24:35-42. Goodman BK, Rutberg J, Lin WW, Pulver AE, Thomas GH. 2000. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J Inherit Metab Dis 23:847-848. Guilmatre A, Dubourg C, Mosca A, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, Laumonnier F, Odent S, Le Vacon G, Joly-Helas G, David V, Bendavid C, Pinoit J, Henry C, Impallomeni C, Germano E, Tortorella G, Di Rosa G, Barthelemy C, Andres C, Faivre L, Frebourg T, Saugier Veber P, Campion D. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947-956. Jacquet H, Berthelot J, Bonnemains C, Simard G, Saugier-Veber P, Raux G, Campion D, Bonneau D, Frebourg T. 2003. The severe form of type I hyperprolinaemia results from homozygous inactivation of the prodh gene. J Med Genet 40:e7. Campbell HD, Webb GC, Young IG. 1997. A human homologue of the Drosophila melanogaster sluggish-a (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia. Hum Genet 101:69-74. Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen Y, Roos JL, Rapoport JL, Gogos JA, Karayiorgou M. 2002. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci USA 99:16859-16864. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940-945. Tournier I, Vezain M, Martins A, Charbonnier F, Baert-Desurmont S, Olschwang S, Wang Q, Buisine MP, Soret J, Tazi J, Frebourg T, Tosi M. 2008. A large fraction of unclassified variants of the mismatch repair genes mlh1 and msh2 is associated with splicing defects. Hum Mutat 29:1412-1424. Mollica F, Pavone L. 1976. Hyperprolinaemia: a disease which does not need treatment?. Acta Paediatr Scand 65:206-208. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. 1999. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434-439. 1976; 65 2009; 66 1962; 267 2001 1973; 54 2000; 23 2008; 29 1965; 272 2004; 67 1997; 101 2004; 24 2002; 11 2002; 99 1999; 56 2005; 76 1999; 21 2005; 10 2001; 16 1975; 85 2003; 40 2003; 100 2006; 136 2007; 16 Valle (10.1002/humu.21296-BIB23|cit23) 1973; 54 Hawkins (10.1002/humu.21296-BIB7|cit7) 2006; 136 Gogos (10.1002/humu.21296-BIB4|cit4) 1999; 21 Phang (10.1002/humu.21296-BIB19|cit19) 2001 Guilmatre (10.1002/humu.21296-BIB6|cit6) 2009; 66 Bender (10.1002/humu.21296-BIB1|cit1) 2005; 76 Goodman (10.1002/humu.21296-BIB5|cit5) 2000; 23 Raux (10.1002/humu.21296-BIB20|cit20) 2007; 16 Tournier (10.1002/humu.21296-BIB22|cit22) 2008; 29 Mollica (10.1002/humu.21296-BIB15|cit15) 1976; 65 Jacquet (10.1002/humu.21296-BIB12|cit12) 2002; 11 Ohtsuki (10.1002/humu.21296-BIB17|cit17) 2004; 67 Liu (10.1002/humu.21296-BIB13|cit13) 2002; 99 Campbell (10.1002/humu.21296-BIB2|cit2) 1997; 101 Jacquet (10.1002/humu.21296-BIB10|cit10) 2003; 40 Hoogendoorn (10.1002/humu.21296-BIB8|cit8) 2004; 24 Efron (10.1002/humu.21296-BIB3|cit3) 1965; 272 Jacquet (10.1002/humu.21296-BIB11|cit11) 2005; 10 Maynard (10.1002/humu.21296-BIB14|cit14) 2003; 100 Schafer (10.1002/humu.21296-BIB21|cit21) 1962; 267 Phang (10.1002/humu.21296-BIB18|cit18) 1975; 85 Humbertclaude (10.1002/humu.21296-BIB9|cit9) 2001; 16 Murphy (10.1002/humu.21296-BIB16|cit16) 1999; 56 |
| References_xml | – reference: Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen Y, Roos JL, Rapoport JL, Gogos JA, Karayiorgou M. 2002. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci USA 99:16859-16864. – reference: Guilmatre A, Dubourg C, Mosca A, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, Laumonnier F, Odent S, Le Vacon G, Joly-Helas G, David V, Bendavid C, Pinoit J, Henry C, Impallomeni C, Germano E, Tortorella G, Di Rosa G, Barthelemy C, Andres C, Faivre L, Frebourg T, Saugier Veber P, Campion D. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947-956. – reference: Campbell HD, Webb GC, Young IG. 1997. A human homologue of the Drosophila melanogaster sluggish-a (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia. Hum Genet 101:69-74. – reference: Humbertclaude V, Rivier F, Roubertie A, Echenne B, Bellet H, Vallat C, Morin D. 2001. Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance. J Child Neurol 16:622-623. – reference: Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC, Buckland PR. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Hum Mutat 24:35-42. – reference: Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. 1999. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434-439. – reference: Phang JM, Downing SJ, Valle DL, Kowaloff EM. 1975. A radioisotopic assay for proline oxidase activity. J Lab Clin Med 85:312-317. – reference: Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, Fantini C, Breviere GM, Di Rosa G, Pustorino G, Vogels A, Swillen A, Legallic S, Bou J, Opolczynski G, Drouin-Garraud V, Lemarchand M, Philip N, Gerard-Desplanches A, Carlier M, Philippe A, Nolen MC, Heron D, Sarda P, Lacombe D, Coizet C, Alembik Y, Layet V, Afenjar A, Hannequin D, Demily C, Petit M, Thibaut F, Frebourg T, Campion D. 2007. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 16:83-91. – reference: Efron ML. 1965. Familial hyperprolinemia. report of a second case, associated with congenital renal malformations, hereditary hematuria and mild mental retardation, with demonstration of an enzyme defect. N Engl J Med 272:1243-1254. – reference: Ohtsuki T, Tanaka S, Ishiguro H, Noguchi E, Arinami T, Tanabe E, Yara K, Okubo T, Takahashi S, Matsuura M, Sakai T, Muto M, Kojima T, Matsushima E, Toru M, Inada T. 2004. Failure to find association between prodh deletion and schizophrenia. Schizophr Res 67:111-113. – reference: Bender H, Almashanu S, Steel G, Hu C, Lin W, Willis A, Pulver A, Valle D. 2005. Functional consequences of prodh missense mutations. Am J Hum Genet 76:409-420. – reference: Hawkins RA, O'Kane RL, Simpson IA, Vina JR. 2006. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136:218S-226S. – reference: Tournier I, Vezain M, Martins A, Charbonnier F, Baert-Desurmont S, Olschwang S, Wang Q, Buisine MP, Soret J, Tazi J, Frebourg T, Tosi M. 2008. A large fraction of unclassified variants of the mismatch repair genes mlh1 and msh2 is associated with splicing defects. Hum Mutat 29:1412-1424. – reference: Valle D, Downing SJ, Phang JM. 1973. Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochem Biophys Res Commun 54:1418-1424. – reference: Jacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, Demilly C, Haouzir S, Allio G, Fouldrin G, Drouin V, Bou J, Petit M, Campion D, Frebourg T. 2002. Prodh mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 11:2243-2249. – reference: Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940-945. – reference: Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, Lerond J, Allio G, Haouzir S, Tillaux A, Bellegou C, Fouldrin G, Delamillieure P, Menard JF, Dollfus S, D'Amato T, Petit M, Thibaut F, Frebourg T, Campion D. 2005. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 10:479-485. – reference: Mollica F, Pavone L. 1976. Hyperprolinaemia: a disease which does not need treatment?. Acta Paediatr Scand 65:206-208. – reference: Schafer IA, Scriver CR, Efron ML. 1962. Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness. N Engl J Med 267:51-60. – reference: Goodman BK, Rutberg J, Lin WW, Pulver AE, Thomas GH. 2000. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J Inherit Metab Dis 23:847-848. – reference: Maynard TM, Haskell GT, Peters AZ, Sikich L, Lieberman JA, LaMantia A. 2003. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci USA 100:14433-14438. – reference: Jacquet H, Berthelot J, Bonnemains C, Simard G, Saugier-Veber P, Raux G, Campion D, Bonneau D, Frebourg T. 2003. The severe form of type I hyperprolinaemia results from homozygous inactivation of the prodh gene. J Med Genet 40:e7. – volume: 40 start-page: e7 year: 2003 article-title: The severe form of type I hyperprolinaemia results from homozygous inactivation of the prodh gene publication-title: J Med Genet – volume: 267 start-page: 51 year: 1962 end-page: 60 article-title: Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness publication-title: N Engl J Med – volume: 67 start-page: 111 year: 2004 end-page: 113 article-title: Failure to find association between prodh deletion and schizophrenia publication-title: Schizophr Res – volume: 136 start-page: 218S year: 2006 end-page: 226S article-title: Structure of the blood–brain barrier and its role in the transport of amino acids publication-title: J Nutr – volume: 100 start-page: 14433 year: 2003 end-page: 14438 article-title: A comprehensive analysis of 22q11 gene expression in the developing and adult brain publication-title: Proc Natl Acad Sci USA – volume: 54 start-page: 1418 year: 1973 end-page: 1424 article-title: Proline inhibition of pyrroline‐5‐carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources publication-title: Biochem Biophys Res Commun – volume: 16 start-page: 83 year: 2007 end-page: 91 article-title: Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome publication-title: Hum Mol Genet – volume: 10 start-page: 479 year: 2005 end-page: 485 article-title: Hyperprolinemia is a risk factor for schizoaffective disorder publication-title: Mol Psychiatry – volume: 16 start-page: 622 year: 2001 end-page: 623 article-title: Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance publication-title: J Child Neurol – volume: 65 start-page: 206 year: 1976 end-page: 208 article-title: Hyperprolinaemia: a disease which does not need treatment? publication-title: Acta Paediatr Scand – volume: 11 start-page: 2243 year: 2002 end-page: 2249 article-title: Prodh mutations and hyperprolinemia in a subset of schizophrenic patients publication-title: Hum Mol Genet – volume: 56 start-page: 940 year: 1999 end-page: 945 article-title: High rates of schizophrenia in adults with velo‐cardio‐facial syndrome publication-title: Arch Gen Psychiatry – volume: 29 start-page: 1412 year: 2008 end-page: 1424 article-title: A large fraction of unclassified variants of the mismatch repair genes mlh1 and msh2 is associated with splicing defects publication-title: Hum Mutat – volume: 23 start-page: 847 year: 2000 end-page: 848 article-title: Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome publication-title: J Inherit Metab Dis – volume: 85 start-page: 312 year: 1975 end-page: 317 article-title: A radioisotopic assay for proline oxidase activity publication-title: J Lab Clin Med – volume: 101 start-page: 69 year: 1997 end-page: 74 article-title: A human homologue of the sluggish‐a (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type‐I hyperprolinaemia publication-title: Hum Genet – volume: 66 start-page: 947 year: 2009 end-page: 956 article-title: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation publication-title: Arch Gen Psychiatry – volume: 76 start-page: 409 year: 2005 end-page: 420 article-title: Functional consequences of prodh missense mutations publication-title: Am J Hum Genet – volume: 21 start-page: 434 year: 1999 end-page: 439 article-title: The gene encoding proline dehydrogenase modulates sensorimotor gating in mice publication-title: Nat Genet – volume: 272 start-page: 1243 year: 1965 end-page: 1254 article-title: Familial hyperprolinemia. report of a second case, associated with congenital renal malformations, hereditary hematuria and mild mental retardation, with demonstration of an enzyme defect publication-title: N Engl J Med – volume: 24 start-page: 35 year: 2004 end-page: 42 article-title: Functional analysis of polymorphisms in the promoter regions of genes on 22q11 publication-title: Hum Mutat – volume: 99 start-page: 16859 year: 2002 end-page: 16864 article-title: Genetic variation in the 22q11 locus and susceptibility to schizophrenia publication-title: Proc Natl Acad Sci USA – start-page: 1821 year: 2001 end-page: 1838 – volume: 67 start-page: 111 year: 2004 ident: 10.1002/humu.21296-BIB17|cit17 article-title: Failure to find association between prodh deletion and schizophrenia publication-title: Schizophr Res doi: 10.1016/S0920-9964(03)00160-9 – volume: 99 start-page: 16859 year: 2002 ident: 10.1002/humu.21296-BIB13|cit13 article-title: Genetic variation in the 22q11 locus and susceptibility to schizophrenia publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.232186099 – volume: 56 start-page: 940 year: 1999 ident: 10.1002/humu.21296-BIB16|cit16 article-title: High rates of schizophrenia in adults with velo-cardio-facial syndrome publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.56.10.940 – volume: 66 start-page: 947 year: 2009 ident: 10.1002/humu.21296-BIB6|cit6 article-title: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.80 – volume: 136 start-page: 218S year: 2006 ident: 10.1002/humu.21296-BIB7|cit7 article-title: Structure of the blood-brain barrier and its role in the transport of amino acids publication-title: J Nutr doi: 10.1093/jn/136.1.218S – volume: 11 start-page: 2243 year: 2002 ident: 10.1002/humu.21296-BIB12|cit12 article-title: Prodh mutations and hyperprolinemia in a subset of schizophrenic patients publication-title: Hum Mol Genet doi: 10.1093/hmg/11.19.2243 – volume: 85 start-page: 312 year: 1975 ident: 10.1002/humu.21296-BIB18|cit18 article-title: A radioisotopic assay for proline oxidase activity publication-title: J Lab Clin Med – volume: 29 start-page: 1412 year: 2008 ident: 10.1002/humu.21296-BIB22|cit22 article-title: A large fraction of unclassified variants of the mismatch repair genes mlh1 and msh2 is associated with splicing defects publication-title: Hum Mutat doi: 10.1002/humu.20796 – volume: 40 start-page: e7 year: 2003 ident: 10.1002/humu.21296-BIB10|cit10 article-title: The severe form of type I hyperprolinaemia results from homozygous inactivation of the prodh gene publication-title: J Med Genet doi: 10.1136/jmg.40.1.e7 – volume: 76 start-page: 409 year: 2005 ident: 10.1002/humu.21296-BIB1|cit1 article-title: Functional consequences of prodh missense mutations publication-title: Am J Hum Genet doi: 10.1086/428142 – volume: 272 start-page: 1243 year: 1965 ident: 10.1002/humu.21296-BIB3|cit3 article-title: Familial hyperprolinemia. report of a second case, associated with congenital renal malformations, hereditary hematuria and mild mental retardation, with demonstration of an enzyme defect publication-title: N Engl J Med doi: 10.1056/NEJM196506172722401 – volume: 100 start-page: 14433 year: 2003 ident: 10.1002/humu.21296-BIB14|cit14 article-title: A comprehensive analysis of 22q11 gene expression in the developing and adult brain publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2235651100 – volume: 101 start-page: 69 year: 1997 ident: 10.1002/humu.21296-BIB2|cit2 article-title: A human homologue of the Drosophila melanogaster sluggish-a (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia publication-title: Hum Genet doi: 10.1007/s004390050589 – volume: 10 start-page: 479 year: 2005 ident: 10.1002/humu.21296-BIB11|cit11 article-title: Hyperprolinemia is a risk factor for schizoaffective disorder publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001597 – volume: 16 start-page: 83 year: 2007 ident: 10.1002/humu.21296-BIB20|cit20 article-title: Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome publication-title: Hum Mol Genet doi: 10.1093/hmg/ddl443 – start-page: 1821 volume-title: The metabolic and molecular bases of inherited disease year: 2001 ident: 10.1002/humu.21296-BIB19|cit19 – volume: 54 start-page: 1418 year: 1973 ident: 10.1002/humu.21296-BIB23|cit23 article-title: Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(73)91144-3 – volume: 21 start-page: 434 year: 1999 ident: 10.1002/humu.21296-BIB4|cit4 article-title: The gene encoding proline dehydrogenase modulates sensorimotor gating in mice publication-title: Nat Genet doi: 10.1038/7777 – volume: 23 start-page: 847 year: 2000 ident: 10.1002/humu.21296-BIB5|cit5 article-title: Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome publication-title: J Inherit Metab Dis doi: 10.1023/A:1026773005303 – volume: 267 start-page: 51 year: 1962 ident: 10.1002/humu.21296-BIB21|cit21 article-title: Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness publication-title: N Engl J Med doi: 10.1056/NEJM196207122670201 – volume: 16 start-page: 622 year: 2001 ident: 10.1002/humu.21296-BIB9|cit9 article-title: Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance publication-title: J Child Neurol doi: 10.1177/088307380101600820 – volume: 65 start-page: 206 year: 1976 ident: 10.1002/humu.21296-BIB15|cit15 article-title: Hyperprolinaemia: a disease which does not need treatment? publication-title: Acta Paediatr Scand doi: 10.1111/j.1651-2227.1976.tb16538.x – volume: 24 start-page: 35 year: 2004 ident: 10.1002/humu.21296-BIB8|cit8 article-title: Functional analysis of polymorphisms in the promoter regions of genes on 22q11 publication-title: Hum Mutat doi: 10.1002/humu.20061 |
| RestrictionsOnAccess | restricted access |
| SSID | ssj0008553 |
| Score | 2.1132748 |
| Snippet | Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline... |
| SourceID | liege hal proquest pubmed crossref wiley istex fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 961 |
| SubjectTerms | 22q11 Adolescent Adult Alleles Amino Acid Metabolism, Inborn Errors - enzymology Amino Acid Metabolism, Inborn Errors - genetics Amino Acid Metabolism, Inborn Errors/enzymology/genetics Case-Control Studies Child Child, Preschool Cognitive science Female Genetic Association Studies Genetics & genetic processes Genotype & phenotype Génétique & processus génétiques Humans Infant Life sciences Male Mutation Mutation, Missense - genetics Neuroscience POX enzymatic activity PRODH Proline - metabolism Proline Oxidase - genetics Sciences du vivant type I hyperprolinemia |
| Title | Type I hyperprolinemia: genotype/phenotype correlations |
| URI | https://api.istex.fr/ark:/67375/WNG-1308DNHV-X/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhumu.21296 https://www.ncbi.nlm.nih.gov/pubmed/20524212 https://www.proquest.com/docview/1766828625 https://www.proquest.com/docview/734000565 https://www.proquest.com/docview/888100696 https://hal.science/hal-00599468 http://orbi.ulg.ac.be/handle/2268/82733 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1059-7794 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1098-1004 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008553 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGEGgvA8bHAgNFgJAApc2XYwfxMgEjINoHINAXZNmOvU7r2qltJuCv585JUw1Nk-ClsZpLFNt39s--8-8IeZrpymJCB7Bv3K2SxgQyYyYwOVeVVipPJZ53Hgyzokw_juhog7xenYVp-CG6DTe0DDdeo4FLteivSUPH9Undg4E3R77tKKHOR_t5zR3FKW2i62kOEDJPO27SuL9-9NxsdMXKGfyOMSLyKjbyT7hO0Hd9Efw8j2bddHRwg_xYVaSJQjnu1UvV07__4nj835reJNstTvX3G8W6RTbMdIdcazJX_toh1wetT_42YbiU9T_4Y7jMT10SIHNyJF_5SP-KO7x9DCNzJV9jLpA2-u4OKQ_efX1TBG06hkDTLMkCy42isVYhy1hodZomCdV5pRMdWwtAQVmAIkxarpWWrLJa24SZKjSR0kyxKrlLNqezqdklPrwJZk5reKV0GlWwumcphYkylzD8hDryyPNVtwjdcpVjyoyJaFiWY4FtIlybeORJJ3vaMHRcKLULvSvkIQydovwSo8M2gsVihLceQ5d3zyLfdrH_SeB_jr0mzfgZfNEzpxGdmJwfY0wco-L78D06BfnbYfFNjDzy0qmMmM3VkTiL3ftcuZ4cCqmFMgIgLxccgGPikb2VYol28FgI5OzE0_0x9Yjf3QazR1-OnJpZvRAsSRFuZ5eIcM4jJKKGCt5rVLb7-DikLhTAIy-c4l3ScKIoB6Ur3f8X4Qdkq4mzwFDJPbK5nNfmIcC3pXrkzPQP0ZY9eg |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYJj5e-BgfCwyIACEBStt8OHZ4mxgjg7YPsEDfLNux12ldO7XNBPz13DlZqqFpErwkVnKJEvvO_tl3_h0hr1JdWkzoAPaNq1XSmECmzAQm46rUSmWJxP3Og2GaF8nnER01sTm4F6bmh2gX3NAyXH-NBo4L0t0Va-i4Oqk60PNm6RrZQAcd2uXu1xV7FKe0jq-nGYDILGnZSaPu6tkL49GalTM4jjEmcgOr-SecJ-i9vgyAXsSzbkDau1NnXV04HkOMQznuVEvV0b__Ynn873-9S243UNXfqXXrHrlmppvkep288tcmuTFo3PL3CcPZrL_vj-E0P3V5gMzJkXzvIwMsLvJ2MZLMlXyN6UCaALwHpNj7ePAhD5qMDIGmaZwGlhtFI616LGU9q5MkjqnOSh3ryFrACsoCGmHScq20ZKXV2sbMlD0TKs0UK-OHZH06m5ot4sObYPC0hpdKJ2EJE3yWUBgrMwk9UE-HHnlz3i5CN3TlmDVjImqi5UhgnQhXJx552cqe1iQdl0ptQfMKeQi9pyi-ReizDWG-GOKtF9Dm7bNIuZ3v9AVecwQ2ScrP4IteO5VoxeT8GMPiGBU_hp_QL8h3h_l3MfLIO6czYjZXR-Iscu9z5WpyKKQWyghAvVxwwI6xR7bPNUs0_cdCIG0nbvCPqEf89jZYPrpz5NTMqoVgcYKIO71ChHMeIhc1_OCjWmfbj4961EUDeOSt07wrKk7kxaBwpcf_Ivyc3MwPBn3R3x9-eUJu1WEXGDm5TdaX88o8BTS3VM-czf4BjmpBlg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwED_tISa-8BiPBQZEgJAA9ZGnHcSXiVE62CrEKPQLsmzHXqd1bdU1E_DXc-ekqYamSfClsZpLFNt39s--8-8Anqc6t5TQAe2bdqukMQ2ZMtMwGVe5ViqLJZ13Puil3X78cZAMVuDt4ixMyQ9Rb7iRZbjxmgx8mtvWkjR0WJwWTRx4s3QV1uMUl1cEib4syaN4kpTh9UmGGDKLa3LSsLV89sJ0tGrlBH-HFBK5Tq38E68jcl5fhj8vwlk3H3Vuwo9FTcowlJNmMVdN_fsvksf_reotuFEBVX-n1KzbsGLGm3CtTF35axM2Diqn_B1gtJb19_whXmZTlwXInB7LNz7xv9IWb4viyFzJ15QMpAq_uwv9zvuv77qNKh9DQydplDYsNyoJtWqzlLWtjuMoSnSW60iH1iJSUBaxCJOWa6Uly63WNmImb5tAaaZYHt2DtfFkbLbAxzfh1GkNz5WOgxyX9yxOcKbMJI4_bR148HLRLUJXZOWUM2MkSprlUFCbCNcmHjyrZaclRcelUlvYu0Ie4dgp-ocheWwDXC0GdOspdnn9LBFud3f2Bf3n6GvilJ_jF71wGlGLydkJBcWxRHzvfSCvIN_tdb-JgQevncqIyUwdi_PQvc-Vi9GRkFooIxDzcsEROUYebC8US1Sjx5kg0k463h8mHvj1bbR7cubIsZkUZ4JFMeHt9AoRznlATNRYwfulytYfH7YTFwvgwSuneFc0nOj2D_qu9OBfhJ_Axufdjtjf6316CNfLmAsKm9yGtfmsMI8Qys3VY2exfwCSX0BF |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Type+I+hyperprolinemia%3A+genotype%2Fphenotype+correlations&rft.jtitle=Human+mutation&rft.au=Guilmatre%2C+Audrey&rft.au=Legallic%2C+Solenn&rft.au=Steel%2C+Gary&rft.au=Willis%2C+Alecia&rft.date=2010-08-01&rft.issn=1059-7794&rft.eissn=1098-1004&rft.volume=31&rft.issue=8&rft.spage=961&rft.epage=965&rft_id=info:doi/10.1002%2Fhumu.21296&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_humu_21296 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1059-7794&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1059-7794&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1059-7794&client=summon |